Direct Oral Anticoagulants (DOAC): Newly Identified Genes and Genetic Variants
January 26, 2019 – Pharmacogenomic approaches are increasingly revealing newly identified genes and genetic variants that are at the base of remarkable inter-individual pharmacokinetic and pharmacodynamic variation of novel direct oral anticoagulants (DOAC). Lately, DOACs have shown an upward prescribing trend due …
Direct Oral Anticoagulants (DOAC): Newly Identified Genes and Genetic Variants Read more »